Related Experiment Video

Updated: Dec 8, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.1K

Re-evaluating the Role of CABG in Acute Coronary Syndromes

Douglas Farmer1,2,3, Ernesto Jimenez4,5,6

  • 1Department of Cardiothoracic Surgery, Baylor College of Medicine, Houston, TX, USA. douglas.farmer@bcm.edu.

Current Cardiology Reports
|September 18, 2020
PubMed

Insights

Coronary artery bypass grafting (CABG) offers survival advantages over percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) patients long-term. Careful patient selection by a heart team is crucial for optimal revascularization strategy and outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Coronary artery bypass grafting (CABG) use has declined in acute coronary syndrome (ACS) patients, with percutaneous coronary intervention (PCI) use increasing.
  • Long-term data indicates superior survival rates for CABG compared to PCI in specific ACS populations.
  • Understanding current indications and outcomes for CABG in ACS is essential.

Purpose of the Study:

  • To review the current indications for coronary artery bypass grafting (CABG) in patients presenting with acute coronary syndrome (ACS).
  • To evaluate the outcomes of CABG in patients with ACS.
  • To compare the long-term effectiveness of CABG versus percutaneous coronary intervention (PCI) in ACS management.

Main Methods:

  • Review of real-world studies and clinical data comparing CABG and PCI outcomes in ACS.
  • Analysis of patient selection criteria and the impact of interdisciplinary heart team decisions.
  • Evaluation of outcomes in specific ACS subgroups, including those with cardiogenic shock.

Main Results:

  • Real-world evidence suggests better long-term outcomes with CABG than PCI following non-ST-elevation ACS (NSTE-ACS).
  • Staged CABG after culprit-vessel PCI for ST-elevation myocardial infarction (STEMI) is a viable strategy for selected patients.
  • Mechanical circulatory support in CABG for ACS with cardiogenic shock showed a significant mortality reduction.

Conclusions:

  • The optimal revascularization strategy post-ACS is multifactorial and patient-specific.
  • Careful patient selection, guided by an interdisciplinary heart team, is paramount for improving outcomes.
  • Despite declining use, CABG remains a critical option with long-term survival benefits for select ACS patients.
Abstract

Keywords:
Acute coronary syndromeCABGPercutaneous interventions

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.6K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.3K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
150
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
119
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
167
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
459
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
243